PCR Trials Book
Explore the latest clinical trials now!
It’s time to explore the newest updates from randomised interventional trials published between October and November 2024. Read each trial summary for a concise overview of the essential information, providing you with useful references and insights for your everyday practice. The PCR Trials Book has just been refreshed with 13 new clinical trials.
Hundreds of randomised trials from 2018-2024 are at your fingertips, sourced from world-renowned publications!
The medical journals from which trials are selected include New England Journal of Medicine, Lancet, JAMA, bmj, European Heart Journal, Journal of the American College of Cardiology, Circulation, Annals of Internal Medicine, EuroIntervention, JACC Cardiovascular Interventions and Circulation Cardiovascular Interventions.
Editors: Pim de Feyter, Robert Byrne
This update brings you summaries of 13 new clinical trials:
- Bioadaptor implant versus contemporary DES in PCI - INFINITY-SWEDEHEART
- Ultrathin vs thin-strut stents with high bleeding risk - COMPARE 60/80 HBR
- Low dose sirolimus-eluting stent vs second-generation DES - TARGET-IV NA
- Drug-coated balloon angioplasty of side branch during provisional stenting - DCB-BIF
- Half-dose Tenecteplase or Primary PCI for STEMI - STREAM-2 1 year
- Quantitative flow ratio versus FFR for guidance PCI - FAVOR III EUROPE
- COBRA PzF stenting to reduce duration of triple therapy - COBRA-REDUCE
- Mechanical support in infarct-related cardiogenic shock - ECLS-SHOCK 1 year
- TAVR for asymptomatic severe aortic stenosis - EARLY TAVR
- TAVI in low-risk tricuspid or bicuspid aortic stenosis - NOTION-2
- TAVR in patients with systolic heart failure and moderate aortic stenosis - TAVR UNLOAD
Released thanks to the support of Translumina
